Mouse DMBT1(Deleted In Malignant Brain Tumors 1) ELISA Kit ELK7784
Specifications
| 48T / 96T |
Product info:
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Deleted In Malignant Brain Tumors 1(DMBT1). Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Deleted In Malignant Brain Tumors 1(DMBT1). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Deleted In Malignant Brain Tumors 1(DMBT1), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Deleted In Malignant Brain Tumors 1(DMBT1) in the samples is then determined by comparing the OD of the samples to the standard curve.
Research area:
Tumor immunity;
Species reactivity:
Mouse
Alternative names:
GP340; SAG; Muclin; Glycoprotein 340; Hensin; Salivary agglutinin; Surfactant pulmonary-associated D-binding protein
Sample type:
tissue homogenates, cell lysates and other biological fluids
Detection range:
Sensitivity:
0.056 ng/mL
Standard:
10 ng/mL
Detection method:
Sandwich
Assay time:
3.5h
More info:
Email: info@sobekbio.com
Orders:
Email: info@sobekbio.com
HansaBioMed: leader in exosome based solutions for Life Sciences HansaBioMed OU is an innovative Company performing research and development in the field of Exosome Sciences. Its mission is to consolidate and maintain the worldwide leadership in production and commercialization of kits, reagents, equipment and services dedicated to exosome research for the Life Science market. HansaBioMed develops, produces and commercializes a wide range of products dedicated to the expanding market of exosome research, which are essential tools for all scientists engaged in this rapidly growing field of science. The best known of HansaBioMed owned brands is the ExoTESTTMplatform, a proprietary immune-based solution to capture, quantify and characterize exosomes from biological fluids.